Benevenuto sul sito del gruppo iCARE-MS

Centro ad Alta Specializzazione per la Ricerca e Cura della Sclerosi Multipla

Nella nostra Biblioteca trovate una serie di monografie messe a disposizione dal gruppo sui temi piu' importanti relativi alla Sclerosi Multipla.


1.     Magliozzi R, Reynolds R, Calabrese M. MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course. Brain Pathol. 2018 Jul

2.     Bajrami A, Pitteri M, Castellaro M, Pizzini F, Romualdi C, Montemezzi S,Monaco S, Calabrese M. The effect of fingolimod on focal and diffuse grey matter damage in active MS patients. J Neurol. 2018 Jun 25.

3.     Calabrese M. Multiple sclerosis and epilepsy: much more than a coincidence. Eur J Neurol. 2018 Sep;25(9):1103-1104

4.     Scalfari A, Romualdi C, Nicholas RS, Mattoscio M, Magliozzi R, Morra A, Monaco S, Muraro PA, Calabrese M. The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis. Neurology. 2018 Jun 12;90(24):e2107-e2118.

5.     Pitteri M, Magliozzi R, Bajrami A, Camera V, Calabrese M. Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables. Expert Opin Pharmacother. 2018 Mar;19(4):387-395.

6.     Magliozzi R, Howell OW, Nicholas R, Cruciani C, Castellaro M, Romualdi C, Rossi S, Pitteri M, Benedetti MD, Gajofatto A, Pizzini FB, Montemezzi S, Rasia S, Capra R, Bertoldo A, Facchiano F, Monaco S, Reynolds R, Calabrese M. Inflammatory intrathecal profiles and cortical damage in multiple sclerosis. Ann Neurol. 2018  Mar

7.     Calabrese M, Pitteri M, Farina G, Bajrami A, Castellaro M, Magliozzi R, Monaco S. Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events. J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1073-1078.

8.     Castellaro M, Magliozzi R, Palombit A, Pitteri M, Silvestri E, Camera V, Montemezzi S, Pizzini FB, Bertoldo A, Reynolds R, Monaco S, Calabrese M. Heterogeneity of Cortical Lesion Susceptibility Mapping in Multiple Sclerosis. AJNR Am J Neuroradiol. 2017 Jun;38(6):1087-1095.

9.     Calabrese M, Castellaro M. Cortical Gray Matter MR Imaging in Multiple Sclerosis. Neuroimaging Clin N Am. 2017 May;27(2):301-312.

10.     Zimatore DS, Trentadue M, Castellaro M, Ferlisi M, Piovan E, Calabrese M. A case of epilepsy in multiple sclerosis: Three-dimensional double inversion recovery sequences revealed cortical dysplasia. Neuroradiol J. 2017 Aug;30(4):352-355.

11.     Farina G, Magliozzi R, Pitteri M, Reynolds R, Rossi S, Gajofatto A, Benedetti MD, Facchiano F, Monaco S, Calabrese M. Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study. J Neuroinflammation. 2017 Feb 21;14(1):40.

12.     Turri G, Calabrese M, Pancheri E, Monaco S, Gajofatto A, Marafioti V. QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? Eur J Neurol. 2017 Mar;24(3):491-496.

13.     Pitteri M, Romualdi C, Magliozzi R, Monaco S, Calabrese M. Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study. Mult Scler. 2017 May;23(6):848-854.

14.     Calabrese M, Castellaro M, Bertoldo A, De Luca A, Pizzini FB, Ricciardi GK, Pitteri M, Zimatore S, Magliozzi R, Benedetti MD, Manganotti P, Montemezzi S, Reynolds R, Gajofatto A, Monaco S. Epilepsy in

multiple sclerosis: The role of temporal lobe damage. Mult Scler. 2017 Mar;23(3):473-482.

15.     Calabrese M, Reynolds R, Magliozzi R, Castellaro M, Morra A, Scalfari A, Farina G, Romualdi C, Gajofatto A, Pitteri M, Benedetti MD, Monaco S. Regional Distribution and Evolution of Gray Matter Damage in

Different Populations of Multiple Sclerosis Patients. PLoS One. 2015 Aug 12;10(8):e0135428.

16.     Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJ, Reynolds R, Martin R. Exploring the origins of grey matter damage in multiple sclerosis. Nat Rev Neurosci. 2015 Mar;16(3):147-58.

17.     Calabrese M, Gajofatto A, Gobbin F, Turri G, Richelli S, Matinella A, Oliboni  ES, Benedetti MD, Monaco S. Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. Mult Scler. 2015 Apr;21(5):580-9.

18.     Calabrese M, Gajofatto A, Benedetti MD. Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. Expert Rev Neurother. 2014 Dec;14(12):1417-28.

19.     Calabrese M, De Stefano N. Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: yes. Mult Scler. 2014 Apr;20(5):537-8.

Le nostre ultime pubblicazioni scientifiche